{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:24:14Z","timestamp":1791473054345,"version":"4.3.4"},"reference-count":45,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The deregulation of the immune response is a critical component in inflammatory disease. Recent in vitro data show that T-cell protein tyrosine phosphatase (TC-PTP) is a negative regulator of cytokine signaling. Furthermore, tc-ptp-\/- mice display immune defects and die within 5 weeks of birth. We report here that tc-ptp-\/- mice develop progressive systemic inflammatory disease as shown by chronic myocarditis, gastritis, nephritis, and sialadenitis as well as elevated serum interferon-\u03b3. The widespread mononuclear cellular infiltrates correlate with exaggerated interferon-\u03b3, tumor necrosis factor-\u03b1, interleukin-12, and nitric oxide production in vivo. Macrophages grown from tc-ptp-\/- mice are inherently hypersensitive to lipopolysaccharide, which can also be detected in vivo as an increased susceptibility to endotoxic shock. These results identify T-cell protein tyrosine phosphatase as a key modulator of inflammatory signals and macrophage function. (Blood. 2004;103:3457-3464)<\/jats:p>","DOI":"10.1182\/blood-2003-09-3153","type":"journal-article","created":{"date-parts":[[2004,1,19]],"date-time":"2004-01-19T20:14:24Z","timestamp":1074543264000},"page":"3457-3464","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":151,"title":["T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease"],"prefix":"10.1182","volume":"103","author":[{"given":"Krista M.","family":"Heinonen","sequence":"first","affiliation":[{"name":"From the Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada; McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC, Canada; and Department of Pathology and Microbiology, University of Nebraska Medical Centre, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick P.","family":"Nestel","sequence":"additional","affiliation":[{"name":"From the Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada; McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC, Canada; and Department of Pathology and Microbiology, University of Nebraska Medical Centre, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan W.","family":"Newell","sequence":"additional","affiliation":[{"name":"From the Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada; McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC, Canada; and Department of Pathology and Microbiology, University of Nebraska Medical Centre, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Charette","sequence":"additional","affiliation":[{"name":"From the Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada; McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC, Canada; and Department of Pathology and Microbiology, University of Nebraska Medical Centre, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Seemayer","sequence":"additional","affiliation":[{"name":"From the Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada; McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC, Canada; and Department of Pathology and Microbiology, University of Nebraska Medical Centre, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel L.","family":"Tremblay","sequence":"additional","affiliation":[{"name":"From the Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada; McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC, Canada; and Department of Pathology and Microbiology, University of Nebraska Medical Centre, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne S.","family":"Lapp","sequence":"additional","affiliation":[{"name":"From the Division of Experimental Medicine, McGill University, Montreal, QC, Canada; Department of Physiology, McGill University, Montreal, QC, Canada; McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC, Canada; and Department of Pathology and Microbiology, University of Nebraska Medical Centre, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222584410900_REF1","doi-asserted-by":"crossref","unstructured":"You-Ten KE, Muise ES, Itie\u0301 A, et al. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med. 1997;186: 683-693.","DOI":"10.1084\/jem.186.5.683"},{"key":"2020021222584410900_REF2","doi-asserted-by":"crossref","unstructured":"Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol. 2002;12: 446-453.","DOI":"10.1016\/S0960-9822(02)00697-8"},{"key":"2020021222584410900_REF3","doi-asserted-by":"crossref","unstructured":"ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol. 2002;22: 5662-5668.","DOI":"10.1128\/MCB.22.16.5662-5668.2002"},{"key":"2020021222584410900_REF4","doi-asserted-by":"crossref","unstructured":"Aoki N, Matsuda T. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol. 2002;16: 58-69.","DOI":"10.1210\/mend.16.1.0761"},{"key":"2020021222584410900_REF5","doi-asserted-by":"crossref","unstructured":"Yamamoto T, Sekine Y, Kashima K, et al. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun. 2002;297: 811-817.","DOI":"10.1016\/S0006-291X(02)02291-X"},{"key":"2020021222584410900_REF6","doi-asserted-by":"crossref","unstructured":"Ibarra-Sanchez MJ, Simoncic PD, Nestel FR, Duplay P, Lapp WS, Tremblay ML. The T-cell protein tyrosine phosphatase. Semin Immunol. 2000;12: 379-386.","DOI":"10.1006\/smim.2000.0220"},{"key":"2020021222584410900_REF7","doi-asserted-by":"crossref","unstructured":"Tracey KJ, Wei H, Manogue KR, et al. Cachectin\/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988;167: 1211-1227.","DOI":"10.1084\/jem.167.3.1211"},{"key":"2020021222584410900_REF8","doi-asserted-by":"crossref","unstructured":"Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330: 662-664.","DOI":"10.1038\/330662a0"},{"key":"2020021222584410900_REF9","doi-asserted-by":"crossref","unstructured":"Ashkenazi A, Marsters SA, Capon DJ, et al. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A. 1991;88: 10535-10539.","DOI":"10.1073\/pnas.88.23.10535"},{"key":"2020021222584410900_REF10","doi-asserted-by":"crossref","unstructured":"Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med. 1992;175: 405-413.","DOI":"10.1084\/jem.175.2.405"},{"key":"2020021222584410900_REF11","doi-asserted-by":"crossref","unstructured":"Kichian K, Nestel FP, Kim D, Ponka P, Lapp WS. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease: possible involvement of IFN-gamma. J Immunol. 1996;157: 2851-2856.","DOI":"10.4049\/jimmunol.157.7.2851"},{"key":"2020021222584410900_REF12","doi-asserted-by":"crossref","unstructured":"Price KS, Nestel FP, Lapp WS. Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease. Scand J Immunol. 1997;45: 294-300.","DOI":"10.1046\/j.1365-3083.1997.d01-404.x"},{"key":"2020021222584410900_REF13","doi-asserted-by":"crossref","unstructured":"Nestel FP, Greene RN, Kichian K, Ponka P, Lapp WS. Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide-mediated cytostasis. Blood. 2000;96: 1836-1843.","DOI":"10.1182\/blood.V96.5.1836"},{"key":"2020021222584410900_REF14","doi-asserted-by":"crossref","unstructured":"Mannel DN, Moore RN, Mergenhagen SE. Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun. 1980;30: 523-530","DOI":"10.1128\/iai.30.2.523-530.1980"},{"key":"2020021222584410900_REF15","doi-asserted-by":"crossref","unstructured":"Gifford GE, Lohmann-Matthes ML. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst. 1987;78: 121-124","DOI":"10.1093\/jnci\/78.1.121"},{"key":"2020021222584410900_REF16","doi-asserted-by":"crossref","unstructured":"Stuehr DJ, Marletta MA. Induction of nitrite\/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J Immunol. 1987;139: 518-525.","DOI":"10.4049\/jimmunol.139.2.518"},{"key":"2020021222584410900_REF17","doi-asserted-by":"crossref","unstructured":"Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol. 1988;141: 2407-2412.","DOI":"10.4049\/jimmunol.141.7.2407"},{"key":"2020021222584410900_REF18","doi-asserted-by":"crossref","unstructured":"Garside P, Hutton AK, Severn A, Liew FY, Mowat AM. Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol. 1992;22: 2141-2145.","DOI":"10.1002\/eji.1830220827"},{"key":"2020021222584410900_REF19","doi-asserted-by":"crossref","unstructured":"Liu JS, Zhao ML, Brosnan CF, Lee SC. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol. 2001;158: 2057-2066.","DOI":"10.1016\/S0002-9440(10)64677-9"},{"key":"2020021222584410900_REF20","doi-asserted-by":"crossref","unstructured":"Bobe P, Benihoud K, Grandjon D, Opolon P, Pritchard LL, Huchet R. Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction. Blood. 1999;94: 1028-1037.","DOI":"10.1182\/blood.V94.3.1028.415k24_1028_1037"},{"key":"2020021222584410900_REF21","doi-asserted-by":"crossref","unstructured":"Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med. 2000;192: 117-122.","DOI":"10.1084\/jem.192.1.117"},{"key":"2020021222584410900_REF22","doi-asserted-by":"crossref","unstructured":"Angulo I, de las Heras FG, Garcia-Bustos JF, Gargallo D, Munoz-Fernandez MA, Fresno M. Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood. 2000;95: 212-220.","DOI":"10.1182\/blood.V95.1.212"},{"key":"2020021222584410900_REF23","doi-asserted-by":"crossref","unstructured":"McCormack JM, Leenen PJ, Walker WS. Macrophage progenitors from mouse bone marrow and spleen differ in their expression of the Ly-6C differentiation antigen. J Immunol. 1993;151: 6389-6398.","DOI":"10.4049\/jimmunol.151.11.6389"},{"key":"2020021222584410900_REF24","doi-asserted-by":"crossref","unstructured":"Schoenhaut DS, Chua AO, Wolitzky AG, et al. Cloning and expression of murine IL-12. J Immunol. 1992;148: 3433-3440.","DOI":"10.4049\/jimmunol.148.11.3433"},{"key":"2020021222584410900_REF25","doi-asserted-by":"crossref","unstructured":"Dupuis M, De Jesus Ibarra-Sanchez M, Tremblay ML, Duplay P. Gr-1+ myeloid cells lacking T cell protein tyrosine phosphatase inhibit lymphocyte proliferation by an IFN-gamma- and nitric oxide-dependent mechanism. J Immunol. 2003;171: 726-732.","DOI":"10.4049\/jimmunol.171.2.726"},{"key":"2020021222584410900_REF26","doi-asserted-by":"crossref","unstructured":"Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2: 907-916.","DOI":"10.1038\/ni1001-907"},{"key":"2020021222584410900_REF27","doi-asserted-by":"crossref","unstructured":"Howard JG. Increased sensitivity to bacterial endotoxin of F-1 hybrid mice undergoing graft-versus-host reaction. Nature. 1961;190: 1122.","DOI":"10.1038\/1901122a0"},{"key":"2020021222584410900_REF28","doi-asserted-by":"crossref","unstructured":"Katschinski T, Galanos C, Coumbos A, Freudenberg MA. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun. 1992;60: 1994-2001.","DOI":"10.1128\/IAI.60.5.1994-2001.1992"},{"key":"2020021222584410900_REF29","doi-asserted-by":"crossref","unstructured":"Dinges MM, Schlievert PM. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Infect Immun. 2001;69: 1256-1264.","DOI":"10.1128\/IAI.69.3.1256-1264.2001"},{"key":"2020021222584410900_REF30","doi-asserted-by":"crossref","unstructured":"Read TE, Harris HW, Grunfeld C, et al. Chylomicrons enhance endotoxin secretion in bile. Infect Immun. 1993;61: 3496-3502.","DOI":"10.1128\/IAI.61.8.3496-3502.1993"},{"key":"2020021222584410900_REF31","doi-asserted-by":"crossref","unstructured":"Ibarra-Sanchez MJ, Wagner J, Ong MT, Lampron C, Tremblay ML. Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-kappaB activation. Oncogene. 2001;20: 4728-4739.","DOI":"10.1038\/sj.onc.1204648"},{"key":"2020021222584410900_REF32","doi-asserted-by":"crossref","unstructured":"Cooke KR, Gerbitz A, Crawford JM, et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest. 2001;107: 1581-1589.","DOI":"10.1172\/JCI12156"},{"key":"2020021222584410900_REF33","doi-asserted-by":"crossref","unstructured":"Cooke KR, Olkiewicz K, Erickson N, Ferrara JL. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res. 2002;8: 441-448.","DOI":"10.1177\/09680519020080061301"},{"key":"2020021222584410900_REF34","doi-asserted-by":"crossref","unstructured":"Teshima T, Ordemann R, Reddy P, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8: 575-581.","DOI":"10.1038\/nm0602-575"},{"key":"2020021222584410900_REF35","doi-asserted-by":"crossref","unstructured":"Leonard WJ. Cytokines and immunodeficiency diseases. Nat Rev Immunol. 2001;1: 200-208.","DOI":"10.1038\/35105066"},{"key":"2020021222584410900_REF36","doi-asserted-by":"crossref","unstructured":"O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak\/Stat pathway. Cell. 2002;109(suppl): S121-S131.","DOI":"10.1016\/S0092-8674(02)00701-8"},{"key":"2020021222584410900_REF37","doi-asserted-by":"crossref","unstructured":"Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378: 88-91.","DOI":"10.1038\/378088a0"},{"key":"2020021222584410900_REF38","doi-asserted-by":"crossref","unstructured":"Dieli F, Sireci G, Russo D, et al. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med. 2000;192: 1645-1652.","DOI":"10.1084\/jem.192.11.1645"},{"key":"2020021222584410900_REF39","doi-asserted-by":"crossref","unstructured":"Ramarathinam L, Niesel DW, Klimpel GR. Salmonella typhimurium induces IFN-gamma production in murine splenocytes: role of natural killer cells and macrophages. J Immunol. 1993;150: 3973-3981.","DOI":"10.4049\/jimmunol.150.9.3973"},{"key":"2020021222584410900_REF40","doi-asserted-by":"crossref","unstructured":"Alexander WS, Starr R, Fenner JE, et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 1999;98: 597-608.","DOI":"10.1016\/S0092-8674(00)80047-1"},{"key":"2020021222584410900_REF41","doi-asserted-by":"crossref","unstructured":"Yasukawa H, Misawa H, Sakamoto H, et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 1999;18: 1309-1320.","DOI":"10.1093\/emboj\/18.5.1309"},{"key":"2020021222584410900_REF42","doi-asserted-by":"crossref","unstructured":"Starr R, Willson TA, Viney EM, et al. A family of cytokine-inducible inhibitors of signalling. Nature. 1997;387: 917-921.","DOI":"10.1038\/43206"},{"key":"2020021222584410900_REF43","doi-asserted-by":"crossref","unstructured":"Wee C, Muise ES, Coquelet O, et al. Promoter analysis of the murine T-cell protein tyrosine phosphatase gene. Gene. 1999;237: 351-360.","DOI":"10.1016\/S0378-1119(99)00332-7"},{"key":"2020021222584410900_REF44","doi-asserted-by":"crossref","unstructured":"Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283: 1544-1548.","DOI":"10.1126\/science.283.5407.1544"},{"key":"2020021222584410900_REF45","doi-asserted-by":"crossref","unstructured":"Johnson TO, Ermolieff J, Jirousek MR. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov. 2002;1: 696-709.","DOI":"10.1038\/nrd895"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/9\/3457\/1699065\/zh800904003457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/9\/3457\/1699065\/zh800904003457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T18:53:24Z","timestamp":1704999204000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/9\/3457\/18557\/Tcell-protein-tyrosine-phosphatase-deletion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-09-3153","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}